129 related articles for article (PubMed ID: 19520161)
21. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
22. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
Numazawa M; Tachibana M
Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
[TBL] [Abstract][Full Text] [Related]
23. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
24. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
Numazawa M; Oshibe M
J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
[TBL] [Abstract][Full Text] [Related]
25. 4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors.
Numazawa M; Tachibana M; Tateda Y
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):431-8. PubMed ID: 8903428
[TBL] [Abstract][Full Text] [Related]
26. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
[TBL] [Abstract][Full Text] [Related]
27. Studies of the time-dependent inactivation of aromatase by 4beta,5beta-epoxy-6-one and 5beta,6beta-epoxy-4-one steroids under various conditions.
Numazawa M; Yamada K
Biol Pharm Bull; 1999 Nov; 22(11):1207-11. PubMed ID: 10598029
[TBL] [Abstract][Full Text] [Related]
28. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
Numazawa M; Mutsumi A; Kigawa H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
[TBL] [Abstract][Full Text] [Related]
29. Substituted C19 steroid analogs as inhibitors of aromatase.
Brueggemeier RW; Snider CE; Counsell RE
Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
Numazawa M; Tominaga T; Watari Y; Tada Y
Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biochemistry of fluorescent aromatase inhibitors.
Chen HH; Brueggemeier RW
Steroids; 1990 Mar; 55(3):123-7. PubMed ID: 2333659
[TBL] [Abstract][Full Text] [Related]
33. Novel aromatase inhibitors by structure-guided design.
Ghosh D; Lo J; Morton D; Valette D; Xi J; Griswold J; Hubbell S; Egbuta C; Jiang W; An J; Davies HM
J Med Chem; 2012 Oct; 55(19):8464-76. PubMed ID: 22951074
[TBL] [Abstract][Full Text] [Related]
34. Biochemical studies of estr-4-ene-3,6,17-trione and 5 alpha-androstan-17-ones with or without a carbonyl function at C-3 and/or C-6 as aromatase inhibitors.
Numazawa M; Mutsumi A; Tachibana M; Nagaoka M
Biol Pharm Bull; 1995 Apr; 18(4):555-8. PubMed ID: 7655426
[TBL] [Abstract][Full Text] [Related]
35. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
Numazawa M; Oshibe M
Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
Li PK; Brueggemeier RW
J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromatase.
Numazawa M; Mutsumi A; Tachibana M; Hoshi K
J Med Chem; 1994 Jul; 37(14):2198-205. PubMed ID: 8035427
[TBL] [Abstract][Full Text] [Related]
38. 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
Giudici D; Ornati G; Briatico G; Buzzetti F; Lombardi P; di Salle E
J Steroid Biochem; 1988; 30(1-6):391-4. PubMed ID: 3386266
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115).
Lesuisse D; Gourvest JF; Benslimane O; Canu F; Delaisi C; Doucet B; Hartmann C; Lefrançois JM; Tric B; Mansuy D; Philibert D; Teutsch G
J Med Chem; 1996 Feb; 39(3):757-72. PubMed ID: 8576919
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids.
Nagaoka M; Watari Y; Yajima H; Tsukioka K; Muroi Y; Yamada K; Numazawa M
Steroids; 2003 Aug; 68(6):533-42. PubMed ID: 12906938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
